CD33 and neoplasm: Seven patients in the testing group exhibited lymphatic tumor emboli in primary cancer, and these patients displayed decreased CD3+CD8+ cells (Figure S6A,B) and increased CD11b+CD14+/CD33+CD14+ M‐MDSC levels (Figure S6G,I).